ATCT-22NRG ONCOLOGY/RTOG 1122: PHASE II DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY OF BEVACIZUMAB WITH OR WITHOUT AMG 386 IN PATIENTS WITH RECURRENT GLIOBLASTOMA OR GLIOSARCOMA Article

cited authors

  • Lee, Eudocia Q; Zhang, Peixin; Wen, Patrick Y; Gerstner, Elizabeth R; Reardon, David A; Aldape, Ken; de Groot, John F; Choe, Kevin S; Raizer, Jeffrey J; Kim, Lyndon J; Chmura, Steven J; Robins, H Ian; Connelly, Jennifer; Battiste, James; Villano, John; Wagle, Naveed; Merrell, Ryan T; Wendland, Merideth; Mehta, Minesh P

fiu authors

publication date

  • November 9, 2015

Digital Object Identifier (DOI)

start page

  • v6

end page

  • v6

volume

  • 17

issue

  • suppl_5